Shavali, Mehrdad
Moradi, Arash
Tahmaseb, Mohammad
Mohammadian, Kamal
Ganji, Shahla Mohammad
Funding for this research was provided by:
Biotechnology Found Foundation (01/16204)
Article History
Received: 14 January 2024
Accepted: 25 April 2024
First Online: 30 April 2024
Declarations
:
: The study underwent a thorough ethical review process by the Ethical Committee of the National Institute of Genetic Engineering and Biotechnology (NIGEB) before receiving approval (Ethical code #: IR.NIGEB.EC.1401.12.14.D). The research team diligently followed all relevant guidelines and regulations to ensure the safety and well-being of all participants. Participants were given a detailed explanation of the research’s purpose and procedures and asked to sign an informed consent form before participating. The consent form described how their clinical samples and personal data would be used throughout the study, which would be conducted under their physician’s supervision. The research team created the informed consent form with great care, and all participants willingly signed it before participating. Participants were free to withdraw their consent at any point during the study. Throughout the study, the research team maintained the highest ethical standards and strictly adhere to all relevant regulations to safeguard the privacy and confidentiality of all participants’ data.
: Not applicable.
: The authors declare no competing interests.